Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

PL EN


Preferences help
enabled [disable] Abstract
Number of results

Journal

2011 | 6 | 2 | 213-219

Article title

Cardiogenic shock in myocardial infarction-results of in-hospital follow-up

Content

Title variants

Languages of publication

EN

Abstracts

EN
The purpose of this study was to present the outcomes of treatment of cardiogenic shock (CS) complicating acute myocardial infarction (AMI) among patients hospitalized from 1999 through 2006. The study enrolled 1003 patients. Group 1 comprised 87 patients presenting with AMI complicated with CS, whereas Group 2 comprised 916 patients presenting with AMI without CS symptoms. Determination of invasive treatment was according to standard guidelines. The endpoint comprised death, stroke, and reocclusion/reinfarction. Follow-up was confined to the intra-hospital period. CS was observed more frequently in cases of ST-elevation MI (STEMI) and right ventricular MI. The transportation and door-to-needle time were shorter in Group 1. CS patients were characterized by a more severe coronary artery disease, higher maximal creatinine kinase levels, lower global ejection fractions, and increased incidence of atrioventricular conduction disorders. The efficacy of percutaneous coronary intervention (PCI) was 82.26% in Group 1 and 95.03% in Group 2. Death occurred in 33.3% of CS patients and in 3.6% of AMI patients (p<0.0001). Our study proved that in a short-term follow-up, PCI is a procedure of high efficacy in CS patients. The short-term follow-up precluded a conclusion of statistically significant benefits from the shortening of the transportation and door-to-needle time.

Publisher

Journal

Year

Volume

6

Issue

2

Pages

213-219

Physical description

Dates

published
1 - 4 - 2011
online
17 - 2 - 2011

Contributors

  • 2nd Department of Cardiology, Zabrze, Silesian Medical University of Katowice, Zabrze, 41-800, Poland
  • 2nd Department of Cardiology, Zabrze, Silesian Medical University of Katowice, Zabrze, 41-800, Poland
  • 2nd Department of Cardiology, Zabrze, Silesian Medical University of Katowice, Zabrze, 41-800, Poland
  • 2nd Department of Cardiology, Zabrze, Silesian Medical University of Katowice, Zabrze, 41-800, Poland
  • 2nd Department of Cardiology, Zabrze, Silesian Medical University of Katowice, Zabrze, 41-800, Poland
  • 2nd Department of Cardiology, Zabrze, Silesian Medical University of Katowice, Zabrze, 41-800, Poland
author
  • 2nd Department of Cardiology, Zabrze, Silesian Medical University of Katowice, Zabrze, 41-800, Poland
  • 2nd Department of Cardiology, Zabrze, Silesian Medical University of Katowice, Zabrze, 41-800, Poland
  • 2nd Department of Cardiology, Zabrze, Silesian Medical University of Katowice, Zabrze, 41-800, Poland
  • 2nd Department of Cardiology, Zabrze, Silesian Medical University of Katowice, Zabrze, 41-800, Poland

References

  • [1] Hochman JS, Buller CE, Sleeper LA. Cardiogenic shock complicated myocardial infarction - etiologies, management and outcome: A Report from the SHOCK Trial Registry. J Am Coll Cardiol 2000; 36:1063–1070 http://dx.doi.org/10.1016/S0735-1097(00)00879-2[Crossref]
  • [2] Menon V, White H, LeJemtel T, Webb JG, Sleeper LA, Hochman JS. The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the Shock Trial Registry. Should we emergently revascularize Occluded Coronaries in cardiogenic shock? J Am Coll Cardiol 2000; 36:1071–1076 http://dx.doi.org/10.1016/S0735-1097(00)00874-3[Crossref]
  • [3] Jacobs AK, Leopold JA, Bates E, Mendes LA, Sleeper LA, White H et al. Cardiogenic shock caused by right ventricular infarction: a report from Shock registry. J Am Coll Cardiol 2003; 41:1273–1279 http://dx.doi.org/10.1016/S0735-1097(03)00120-7[Crossref]
  • [4] The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J. 2000; 21:1502–1513; J Am Coll Cardiol. 2000; 36:959–69 http://dx.doi.org/10.1053/euhj.2000.2305[Crossref]
  • [5] Holmes DR Jr. Cardiogenic shock: A lethal complication of acute myocardial infarction. Rev Cardiovasc Med 2003 Summer;4(3):131–135
  • [6] Bates ER, Topol EJ. Limitation of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. J Am Coll Cardiol 1991; 18:1077–1084 http://dx.doi.org/10.1016/0735-1097(91)90770-A[Crossref]
  • [7] Gruppo Italiano per lo Studio della Streptochinasi nell’Infarcto Miocardico (GISSI). Effectivness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1:397–401
  • [8] De Luca G, Savonitto S, Greco C, Parodi G, Dajelli Ermolli NC, Silva C et al. BLITZ Investigators Cardiogenic shock developing in the coronary care unit in patients with ST-elevation myocardial infarction. J Cardiovasc Med (Hagerstown). 2008 Oct;9(10):1023–1029 http://dx.doi.org/10.2459/JCM.0b013e328304ae7f[WoS][Crossref]
  • [9] Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V et al. One-Year Survival Following Early Revascularization for cardiogenic shock. JAMA 2001;285(2):190–192 http://dx.doi.org/10.1001/jama.285.2.190[Crossref]
  • [10] Jeger RV, Harkness SM, Ramanathan K, Buller CE, Pfisterer ME, Sleeper LA et al. Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry. Eur Heart J. 2006 Mar;27(6):664–670 http://dx.doi.org/10.1093/eurheartj/ehi729[Crossref]
  • [11] Tarantini G, Ramondo A, Napodano M, Balato C, Isabella G, Razzolini R et al. Myocardial perfusion grade and survival after percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. Am J Cardiol. 2004 May 1;93(9):1081–1085 http://dx.doi.org/10.1016/j.amjcard.2004.01.031[Crossref]
  • [12] Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Serantoni C et al. Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction. Eur Heart J 2006; 27(13):1550–1557 http://dx.doi.org/10.1093/eurheartj/ehl006[Crossref]
  • [13] Thiele H, Smalling RW, Schuler GC. Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2007 Sep;28(17):2057–2063 http://dx.doi.org/10.1093/eurheartj/ehm191[Crossref]
  • [14] Santa-Cruz RA, Cohen MG, Ohman EM. Aortic counterpulsation: a review of the hemodynamic effects and indications for use. Catheter Cardiovasc Interv. 2006 Jan;67(1):68–77 http://dx.doi.org/10.1002/ccd.20552[Crossref]
  • [15] Holmes DR Jr, Bates ER, Kleiman NS, Sadowski Z, Horgan JH, Morris DC et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol 1995; 26:668–674 http://dx.doi.org/10.1016/0735-1097(95)00215-P[Crossref]
  • [16] Gąsior M, Wasilewski J, Gierlotka M, Zębik T, Szkodziński J, Kondys M et al. Cardiogenic shock in the course of myocardial infarction - the results of treatment during hospitalization and in long-term follow-up. Wiad Lek 2003; 56(1–2):4–9
  • [17] Wong SC, Sanborn T, Sleeper LA, Webb JG, Pilchik R, Hart D et al. Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the shock Trial Registry. J Am Coll Cardiol. 2000; 36:1077–1083 http://dx.doi.org/10.1016/S0735-1097(00)00873-1[Crossref]
  • [18] Barbash IM, Behar S, Battler A, Hasdai D, Boyko V, Gottlieb S et al. Management and outcome of cardiogenic shock complicating acute myocardial infarction in hospitals with and without on-site catheterisation facilities. Heart. 2001 Aug;86(2):145–149 http://dx.doi.org/10.1136/heart.86.2.145[Crossref]
  • [19] Lee MS, Tseng CH, Barker CM, Menon V, Steckman D, Shemin R et al. Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease. Ann Thorac Surg. 2008 Jul;86(1):29–34 http://dx.doi.org/10.1016/j.athoracsur.2008.03.019[Crossref]
  • [20] White HD, Assmann SF, Sanborn TA, Jacobs AK, Webb JG, Sleeper LA et al. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation. 2005 Sep 27;112(13):1992–2001 http://dx.doi.org/10.1161/CIRCULATIONAHA.105.540948[Crossref]
  • [21] Webb JG, Lowe AM, Sanborn TA, White HD, Sleeper LA, Carere RG et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol. 2003 Oct 15;42(8):1380–1386 http://dx.doi.org/10.1016/S0735-1097(03)01050-7[Crossref]

Document Type

Publication order reference

Identifiers

YADDA identifier

bwmeta1.element.-psjd-doi-10_2478_s11536-010-0076-8
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.